Patents by Inventor Eileen Jackson

Eileen Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11591367
    Abstract: The present invention relates to novel selective melanocortin-1 receptor (MC1R) agonists as well as the use thereof as skin tanning agents.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: February 28, 2023
    Assignee: DSM IP ASSETS B.V.
    Inventors: Marc Heidl, Eileen Jackson
  • Patent number: 11168054
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: November 9, 2021
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Publication number: 20210277058
    Abstract: The present invention relates to novel selective melanocortin-1 receptor (MC1R) agonists as well as the use thereof as skin tanning agents.
    Type: Application
    Filed: October 2, 2017
    Publication date: September 9, 2021
    Inventors: Marc HEIDL, Eileen JACKSON
  • Patent number: 10849838
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: December 1, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Patent number: 10836791
    Abstract: The present invention relates to novel compounds which effectively inhibit the melanin synthesis in human melanocytes and are thus suitable for the treatment of senile lentigines, for smoothening skin color irregularities and/or for lightening natural skin color.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: November 17, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Marc Heidl, Eileen Jackson
  • Publication number: 20200308222
    Abstract: The present invention relates to novel tetrapeptides as well as the use thereof as antimicrobial agents.
    Type: Application
    Filed: October 29, 2018
    Publication date: October 1, 2020
    Inventors: Marc HEIDL, Eileen JACKSON
  • Publication number: 20200290960
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: September 17, 2020
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • Patent number: 10570075
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: February 25, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Patent number: 10561702
    Abstract: The present invention relates to a novel use of proline containing dipeptides for the prevention and/or treatment of skin conditions associated with altered, damaged or malfunctioning sebaceous glands.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: February 18, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Remo Campiche, Dominik Imfeld, Eileen Jackson, Eliane Ursula Wandeler
  • Patent number: 10550097
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: February 4, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stéphanie Boudon, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Patent number: 10470991
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: November 12, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stephanie Boudon, Marc Heidl, Eileen Jackson
  • Publication number: 20190290563
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: September 26, 2019
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • Publication number: 20190263858
    Abstract: The present invention relates to novel compounds which effectively inhibit the melanin synthesis in human melanocytes and are thus suitable for the treatment of senile lentigines, for smoothening skin color irregularities and/or for lightening natural skin color.
    Type: Application
    Filed: September 13, 2017
    Publication date: August 29, 2019
    Inventors: Marc HEIDL, Eileen JACKSON
  • Patent number: 10336675
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: July 2, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Patent number: 10179797
    Abstract: This invention relates to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), to cosmetic and pharmaceutical compositions containing them, and to their use in the prevention and/or treatment of ailments associated with MMP-12. Formula (I).
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: January 15, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stéphanie Boudon, Eileen Jackson, Rolf Schuetz, Jürgen Herbert Vollhardt, Peter Wikstroem, Eliane Ursula Wandeler
  • Publication number: 20190002378
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: January 3, 2019
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • Publication number: 20180362428
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: December 20, 2018
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • Publication number: 20180353563
    Abstract: The present invention relates to a novel use of proline containing dipeptides for the prevention and/or treatment of skin conditions associated with altered, damaged or malfunctioning sebaceous glands.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 13, 2018
    Inventors: Remo CAMPICHE, Dominik IMFELD, Eileen JACKSON, Eliane Ursula WANDELER
  • Publication number: 20180344604
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 6, 2018
    Inventors: Stephanie BOUDON, Marc HEIDL, Eileen JACKSON
  • Publication number: 20180319829
    Abstract: This invention relates to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), to cosmetic and pharmaceutical compositions containing them, and to their use in the prevention and/or treatment of ailments associated with MMP-12. Formula (I).
    Type: Application
    Filed: November 23, 2016
    Publication date: November 8, 2018
    Inventors: Stéphanie BOUDON, Eileen JACKSON, Rolf SCHUETZ, Jürgen Herbert VOLLHARDT, Peter WIKSTROEM, Eliane Ursula WANDELER